: Fragile-X syndrome includes mental and physical defects, and is the most common form of inherited mental retardation (reviewed in: 1, 2-5). Defects have been observed in dendritic spines (6), and there are defects in the number and function of synapses (7). The disease is associated with loss-of-function mutations in the FMRI gene, usually by trinucleotide repeat expansion (8-12). FMR1 encodes an RNA binding protein (FMRP), which is widely expressed and has been proposed to act in the regulation of mRNA trafficking from the nucleus to specific cytoplasmic compartments and/or to have a role in the regulation of translation (13-27). There are two similar genes in humans (FXR1 and FXR2), and their products may act somewhat redundantly with FMRP (28-30). Some other proteins have been found in a ribonucleoprotein (RNP) complex with FMRP, and there are likely to be more (22, 31-33). A mouse model has been developed (by gene disruption), but this has produced some contradictory results (34-43). A single FMR1 homolog has been found in Drosophila, and ectopic expression of this protein in the fly causes developmental defects (44). While progress has been made in identifying protein partners of FMRP and its mRNA targets, this work has been difficult and there are likely to be many more genes that interact functionally with FMR1. We propose to discover and characterize novel genes that interact with FMR1 towards the long-term objective of improved therapeutic intervention. We have characterized true loss-of-function mutations in the Drosophila gene (Fmr1) and have studied the effects of the ectopic expression of the mouse FMR1 homolog in the fly. We have developed an F1 genetic screen based on the modification of the Drosophila Fmrl mis-expression phenotype in the compound eye, and pilot runs have validated our approach. We now propose two specific aims: 1) To complete the genetic screens, and map and characterize the resulting mutations at the genetic and phenotypic levels. 2) To begin the molecular isolation of the genes discovered and to correlate these to homologs in the human genome.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21NS043536-01
Application #
6474343
Study Section
Special Emphasis Panel (ZNS1-SRB-S (01))
Program Officer
Nichols, Paul L
Project Start
2002-05-15
Project End
2004-04-30
Budget Start
2002-05-15
Budget End
2003-04-30
Support Year
1
Fiscal Year
2002
Total Cost
$180,500
Indirect Cost
Name
Emory University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Zarnescu, Daniela C; Jin, Peng; Betschinger, Joerg et al. (2005) Fragile X protein functions with lgl and the par complex in flies and mice. Dev Cell 8:43-52
Jin, Peng; Zarnescu, Daniela C; Zhang, Fuping et al. (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39:739-47